Antibodies That Coat a ‘Good’ Vaginal Bacterium May Help Guard Against Preterm Birth

One of the most stubborn puzzles in reproductive medicine is why some pregnancies end too early despite the absence of any obvious infection or complication. Spontaneous preterm birth, the leading cause of death in children under five worldwide, has long been linked to imbalances in the microbial communities that live in the vagina, but the immune mechanisms connecting those communities to the timing of labor have remained murky. A new study published in the journal Microbiome by researchers at Imperial College London and their collaborators now offers an unexpected clue: the very antibodies that usually flag pathogens for destruction appear to coat a beneficial vaginal bacterium, and women whose immune systems do this are more likely to deliver at term.

The research team, led by Belen Gimeno-Molina and Lynne Sykes, set out to examine how the maternal immune system interacts with the cervicovaginal microbiota in women at high risk of spontaneous preterm birth. Rather than simply measuring which bacteria were present, the investigators asked a subtler question: which of those bacteria were being recognized and bound by immunoglobulins, the antibody molecules that patrol mucosal surfaces throughout the body. Immunoglobulins are known to be present in cervicovaginal fluid, and previous work had shown that concentrations of IgG, the most abundant antibody class in blood and tissues, are lower in women whose vaginal communities are dominated by Lactobacillus species compared with women carrying more diverse, Lactobacillus-depleted communities. What remained unclear was whether these antibodies played any role in determining pregnancy outcome.

To answer that question, the team studied 100 women considered to be at high risk of spontaneous preterm birth, of whom 48 ultimately delivered preterm and 53 delivered at term. Using flow cytometry, a technique that allows individual bacterial cells to be sorted and analyzed one by one, the researchers could quantify precisely what proportion of the bacteria in each woman’s cervicovaginal fluid was coated with antibodies. The bacteria were first stained with a fluorescent dye that labels all microbial cells, and then fluorescently tagged antibodies against human IgG and IgA were used to detect immune binding. A carefully optimized gating strategy allowed the team to distinguish genuinely coated bacteria from background fluorescence, and control experiments confirmed that relevant vaginal species, including Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis, could be reliably detected by the method.

The results overturned a common assumption. Antibody coating is usually interpreted as a sign that the immune system is fighting an invader, yet in this study the highest proportions of IgG-coated bacteria were found in women whose vaginal communities were dominated by Lactobacillus, and especially by Lactobacillus crispatus, the species most consistently associated with reproductive health. In contrast, women with high-diversity, Lactobacillus-depleted communities, classified as community state type IV, showed lower levels of bacterial coating. In other words, the antibody response appeared to be directed at, or at least coexisting with, the microbes considered most protective rather than at the potentially harmful ones.

Delving deeper into the antibody classes involved, the researchers found a strong positive correlation between total IgG coating and coating by the IgG2 subclass, indicating that IgG2 was the dominant antibody subtype bound to the vaginal bacteria. This detail matters because different IgG subclasses recruit different arms of the immune system. IgG2 is typically associated with responses to polysaccharide antigens and tends to be less inflammatory than subclasses such as IgG1 or IgG3. Consistent with a calming rather than an activating role, the percentage of bacteria coated by IgG and IgG2 was significantly higher in women who delivered at term compared with those who delivered preterm, and the degree of IgG coating correlated negatively with the concentrations of pro-inflammatory immune mediators measured in the cervicovaginal fluid. Women with more antibody-coated bacteria, in short, carried less inflammation in the very compartment where labor is thought to be triggered.

Having established that antibodies were binding to Lactobacillus crispatus, the team went hunting for the molecular targets. Bacteria of this species decorate their surfaces with so-called S-layer proteins, or SLPs, a crystalline lattice of proteins that forms the outermost layer of the cell wall. When the researchers tested whether antibodies from the cervicovaginal fluid and from blood plasma could recognize these proteins, they found that both IgG and IgG2 bound to the S-layer proteins of Lactobacillus crispatus. There was considerable variability between individual women in the levels of antibodies directed against the two S-layer proteins studied, but the identification of these proteins as antibody targets provides the first concrete molecular handle on how the immune system might engage a beneficial vaginal bacterium in a way that is associated with immune homeostasis.

The authors interpret these findings as evidence of a mucosal microbe-immune homeostasis: a state in which the host immune system and the dominant microbial residents coexist in a regulated equilibrium. In this model, IgG coating of Lactobacillus crispatus is not a sign of conflict but of recognition, a form of immune engagement that coincides with low inflammation and, ultimately, with delivery at term. The study cannot prove causation, since it is observational and the antibody coating may be a consequence rather than a cause of a stable microbial community, but the association with pregnancy outcome held even within a cohort of women all considered high risk, which strengthens the biological plausibility of the link.

The work also reframes how scientists think about antibody responses at mucosal surfaces more broadly. In the gut, IgA coating of commensal bacteria is well established as a mechanism that keeps beneficial microbes in place and prevents them from triggering inflammation, a phenomenon sometimes described as immune inclusion rather than immune exclusion. The new findings suggest that an analogous process may operate in the vagina during pregnancy, with IgG, rather than IgA, taking the leading role. Notably, the researchers found that IgA coating did not differ significantly between women delivering at term and preterm, underscoring that the IgG response, and specifically its IgG2 component, is the signal most tightly linked to outcome.

Translational implications follow naturally from the identification of S-layer proteins as candidate antibody targets. If specific antibody profiles against Lactobacillus crispatus SLPs turn out to predict term delivery, they could form the basis of a biomarker test to identify which high-risk women are most likely to benefit from interventions aimed at establishing or maintaining a Lactobacillus crispatus-dominated vaginal community. Longer term, the S-layer proteins themselves might even serve as targets for therapies designed to encourage the immune system to embrace, rather than reject, the vaginal microbiota most associated with healthy pregnancy. The team cautions that much more work is needed, including longitudinal studies in larger and more diverse populations and experiments that directly test whether antibody coating influences bacterial function, before any clinical application can be contemplated.

For now, the study adds an important piece to the growing picture of pregnancy as a state of carefully negotiated coexistence between mother and microbes. Spontaneous preterm birth has resisted decades of effort to find reliable predictors and preventive treatments, and most research has focused on the inflammatory side of the equation, cataloguing the bacteria and immune signals present when labor begins too soon. By turning attention to the quieter half of the story, the antibodies that recognize and apparently tolerate a health-associated bacterium, the Imperial College team and their collaborators suggest that protection against early birth may lie not only in the absence of harmful inflammation but in the presence of a specific, measured immune engagement with the microbes women already carry. The 100 women who contributed samples to the study, recruited through the Imperial Academic Health Science Centre Women’s Health Research Centre, have thereby helped reveal that the boundary between immune defense and immune partnership is far blurrier than textbooks once implied, and that understanding that boundary may prove essential to keeping pregnancies on schedule.

Subject of Research: IgG antibody coating of Lactobacillus crispatus in the cervicovaginal microbiota and its association with immune homeostasis and reduced preterm birth

Article Title: IgG coating of Lactobacillus crispatus is associated with cervicovaginal immune homeostasis and reduced preterm birth rates, identifying S-layer proteins as candidate antibody targets

Article References: Gimeno-Molina, B., Decout, A., Love, R. L., Lee, Y. S., Ng, S., Malik, Z., Chan, D., Roberts, L. A., Bura, S., Mountain, K. E., Bayar, E., David, A. L., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Collado, M. C., & Sykes, L. (2026). IgG coating of Lactobacillus crispatus is associated with cervicovaginal immune homeostasis and reduced preterm birth rates, identifying S-layer proteins as candidate antibody targets. Microbiome. https://doi.org/10.1186/s40168-026-02549-9

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02549-9

Keywords: preterm birth, vaginal microbiota, Lactobacillus crispatus, IgG, immunoglobulin coating, S-layer proteins, cervicovaginal fluid, immune homeostasis, flow cytometry, mucosal immunity, pregnancy, microbiome